Bioavailability Monograph—Warfarin

Deykin, 1970, N. Engl. J. Med., 283, 691, 10.1056/NEJM197009242831307 Lewis, 1970, J. Clin. Invest., 49, 907, 10.1172/JCI106310 Bove, 1972, J. Maine Med. Ass., 63, 159 Wagner, 1971, J. Pharm. Sci., 60, 666, 10.1002/jps.2600600503 O’Reilly, 1966, J. Pharm. Sci., 55, 435, 10.1002/jps.2600550420 O’Reilly, 1964, Throm. Diath. Haemorrh., 11, 1, 10.1055/s-0038-1654801 Hiskey, 1962, J. Pharm. Sci., 51, 43, 10.1002/jps.2600510106 O’Reilly, 1969, J. Clin. Invest., 48, 193, 10.1172/JCI105968 O’Reilly, 1974, Clin. Pharmacol. Ther., 16, 348, 10.1002/cpt1974162348 Levy, 1974, Res. Commun. Chem. Pathol. Pharmacol., 7, 359 O’Reilly, 1962, Throm. Diath. Haemorrh., 8, 82 Welling, 1970, J. Pharm. Sci., 59, 1621, 10.1002/jps.2600591116 Vesell, 1974, Science., 184, 466, 10.1126/science.184.4135.466 Baman, 1974, Res. Commun. Chem. Pathol. Pharmacol., 9, 379 O’Reilly, 1972, Pharmacology., 8, 181 Berson, 1953, J. Clin. Invest., 32, 746, 10.1172/JCI102789 O’Reilly, 1971, Throm. Diath. Haemorrh., 25, 178, 10.1055/s-0038-1654292 Corn, 1967, Clin. Chern., 13, 126, 10.1093/clinchem/13.2.126 Nagashima, 1969, J. Pharm. Sci., 58, 845, 10.1002/jps.2600580711 Lewis, 1969, Clin. Res., H, 332 Fishwick, 1967, Analyst., 92, 192, 10.1039/an9679200192 Kaiser, 1974, J. Pharm. Sci., 63, 1579, 10.1002/jps.2600631018 Midha, 1974, J. Pharm. Sci., 63, 1725, 10.1002/jps.2600631112 Wagner, 1971, J. Pharm. Sci., 60, 1272, 10.1002/jps.2600600845 Lewis, 1971, J. Pharm. Sci., 60, 1271, 10.1002/jps.2600600844 1975 Chaudry, 1972, J. Pharm. Sci., 61, 1121, 10.1002/jps.2600610718 Krantz and Carr’s PharmaCologiC Principles of Medical Practice, 1972, 577 Udall, 1970, N. Engl. J, Med., 283, 1345 O’Reilly, 1968, Circulation, 38, 169, 10.1161/01.CIR.38.1.169 Best and Taylor, 1973, 75 Poole, 1969, Drug Inform. Bull., 3, 8